Related content

Is oral combination therapy with a proton-pump inhibitor and H2 receptor antagonist effective as initial treatment?

By Inamori Masahiko   Akimoto Keiko   Akiyama Tomoyuki   Fujita Koji   Takahashi Hirokazu   Yoneda Masato   Abe Yasunobu   Kirikoshi Hiroyuki   Kubota Kensuke   Saito Satoru   Ueno Norio   Nakajima Atsushi  

Journal of Gastroenterology, Vol. 42, Iss. 6, 2007-06 ,pp. : 510-511

Springer Publishing Company

Access to resources Recommend Favorite

Is an intravenous histamine H2 receptor antagonist superior to an intravenous proton pump inhibitor in acid suppression?

By Kinoshita Yoshikazu   Ishihara Shunji  

Journal of Gastroenterology, Vol. 39, Iss. 1, 2004-01 ,pp. : 92-93

Springer Publishing Company

Access to resources Recommend Favorite

Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor

By Jianu Constantin S   Lange Ove J   Viset Trond   Qvigstad Gunnar   Martinsen Tom C   Fougner Reidun   Kleveland Per M   Fossmark Reidar   Hauso Øyvind   Waldum Helge L  

Scandinavian Journal of Gastroenterology, Vol. 47, Iss. 1, 2012-01 ,pp. : 64-67

Informa Healthcare

Access to resources Recommend Favorite

Adverse Effects of Long-Term Proton Pump Inhibitor Therapy

By Sheen Edward   Triadafilopoulos George  

Digestive Diseases and Sciences, Vol. 56, Iss. 4, 2011-04 ,pp. : 931-950

Springer Publishing Company

Access to resources Recommend Favorite

Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan

By Hongo Michio   Fujimoto Kazuma  

Journal of Gastroenterology, Vol. 45, Iss. 6, 2010-06 ,pp. : 618-624

Springer Publishing Company

Access to resources Recommend Favorite